Last reviewed · How we verify

Ketofol(ketamine+propofol) — Competitive Intelligence Brief

Ketofol(ketamine+propofol) (Ketofol(ketamine+propofol)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fixed-dose combination anesthetic. Area: Anesthesia.

marketed Fixed-dose combination anesthetic NMDA receptor (ketamine); GABA-A receptor (propofol) Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Ketofol(ketamine+propofol) (Ketofol(ketamine+propofol)) — Post Graduate Institute of Medical Education and Research, Chandigarh. Ketofol is a fixed-dose combination of ketamine (NMDA receptor antagonist) and propofol (GABA-A agonist) that produces rapid sedation and anesthesia with preserved airway reflexes and hemodynamic stability.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ketofol(ketamine+propofol) TARGET Ketofol(ketamine+propofol) Post Graduate Institute of Medical Education and Research, Chandigarh marketed Fixed-dose combination anesthetic NMDA receptor (ketamine); GABA-A receptor (propofol)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fixed-dose combination anesthetic class)

  1. Post Graduate Institute of Medical Education and Research, Chandigarh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ketofol(ketamine+propofol) — Competitive Intelligence Brief. https://druglandscape.com/ci/ketofol-ketamine-propofol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: